Omnicuris Logo
Peritruncal Hematoma Volume: A Superior Prognostic Marker in aSAH

Peritruncal Hematoma Volume: A Superior Prognostic Marker in aSAH

Read More
Full Text
2 days back

Introduction to Prognostic Markers in aSAH


Radiological grading scales play a vital role in managing aneurysmal subarachnoid hemorrhage (aSAH). Currently, clinicians rely heavily on the modified Fisher scale to predict secondary complications. However, these traditional systems focus primarily on supratentorial blood distribution. Recent evidence suggests that peritruncal hematoma volume may offer a more accurate representation of patient risk. Because the brainstem is functionally critical, overlooking blood in this region could limit the predictive accuracy of standard grading tools.



Research Findings on Peritruncal Blood


A large retrospective study involving 675 patients recently investigated the impact of blood volume in the peritruncal cisterns. Researchers manually segmented blood in the interpeduncular, prepontine, premedullary, and magna cisterns. Notably, they found that peritruncal blood volume independently associates with functional outcomes at discharge and six months. Specifically, this marker showed a stronger correlation with long-term recovery than either the Fisher or modified Fisher scales. Furthermore, the volume of blood in these infratentorial compartments significantly predicted the eventual need for a ventriculoperitoneal shunt (VPS).



Clinical Utility of Peritruncal Hematoma Volume


Consequently, the study highlights a potential gap in current neuro-imaging assessments. Higher peritruncal volumes remained prognostic even in patients with anterior circulation aneurysms. Therefore, incorporating these components into existing supratentorial scales could enhance clinical utility. This approach might allow neuro-intensivists to identify high-risk patients earlier. Moreover, automated volumetric tools may soon simplify the measurement of peritruncal hematoma volume in busy emergency settings across India. While these findings are exploratory, they suggest a shift toward more quantitative and anatomically inclusive grading systems.



Frequently Asked Questions


What is the clinical significance of peritruncal hematoma volume?


Peritruncal blood volume measures the amount of hemorrhage around the brainstem. It serves as a robust predictor of shunt dependency and long-term functional disability after aSAH.



How does it compare to the modified Fisher scale?


Research indicates that peritruncal volumes have a stronger association with functional recovery at six months compared to the supratentorially focused Fisher-based scales.



Should this change current management in aSAH?


While the findings warrant further validation, they suggest that clinicians should pay closer attention to infratentorial blood during initial CT reviews for better risk stratification.



Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.



References


Neyazi M et al. Peritruncal hematoma volume: is it a neglected prognostic marker in aneurysmal subarachnoid hemorrhage? J Neurosurg. 2026 Apr 24. doi: 10.3171/2025.12.JNS252313. PMID: 42030566.


Kim et al. Volumetric blood cutoff for outcome prediction in aneurysmal subarachnoid hemorrhage using semiautomated quantification. PMC, 2024.


Connolly ES Jr et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2012.

"
Login to continue

More from MedShots Daily

Peritruncal Hematoma Volume: A Superior Prognostic Marker in aSAH
Peritruncal Hematoma Volume: A Superior Prognostic Marker in aSAH

Research indicates peritruncal hematoma volume is a significant prognostic marker in aSAH, outperforming the modified Fisher scale for functional outcomes....

2 days back

Read More
Full Text
Max Healthcare Joins Indo-EU Dengue Research Consortium
Max Healthcare Joins Indo-EU Dengue Research Consortium

Max Healthcare joins Indo-EU COMBAT initiative to advance dengue research using multi-omics and AI for early diagnosis and better patient outcomes....

Today

Read More
Full Text
Apollo Launches India's First Gynae-Oncology Ecosystem
Apollo Launches India's First Gynae-Oncology Ecosystem

Apollo Athenaa launches India's first integrated gynae-oncology and robotic surgery ecosystem to streamline cancer care and improve outcomes for Indian wome...

Today

Read More
Full Text
The Hidden Economic Burden of Heart Failure in India
The Hidden Economic Burden of Heart Failure in India

Study finds 7 in 10 Indian heart failure patients lack insurance, with average annual costs exceeding ₹1 lakh, leading to catastrophic financial distress....

Today

Read More
Full Text
Fortis Bengaluru Launches New Preventive Genomics Clinic
Fortis Bengaluru Launches New Preventive Genomics Clinic

Fortis Hospitals Bengaluru has launched a Preventive Genomics Clinic to offer advanced genetic diagnostics, prenatal screening, and personalized medicine....

Today

Read More
Full Text
Bihar's Alcohol Ban: Slashing Liver Disease Rates
Bihar's Alcohol Ban: Slashing Liver Disease Rates

Bihar's prohibition has significantly reduced alcohol-related diseases like liver cirrhosis while improving nutritional intake and metabolic health markers....

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris